Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy.
Brun JL, Dalstein V, Leveque J, Mathevet P, Raulic P, Baldauf JJ, Scholl S, Huynh B, Douvier S, Riethmuller D, Clavel C, Birembaut P, Calenda V, Baudin M, Bory JP.
Brun JL, et al. Among authors: douvier s.
Am J Obstet Gynecol. 2011 Feb;204(2):169.e1-8. doi: 10.1016/j.ajog.2010.09.020.
Am J Obstet Gynecol. 2011.
PMID: 21284968
Clinical Trial.